echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > NEJM Editor-in-Chief Classroom: New Trends in Tumor Immunotherapy (Part I) ASCO 2021 warm-up

    NEJM Editor-in-Chief Classroom: New Trends in Tumor Immunotherapy (Part I) ASCO 2021 warm-up

    • Last Update: 2021-06-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On the occasion of ASCO 2021, the annual event of clinical oncology, NEJM Medical Frontier invited Dr.
    Dan Longo, the editor in charge of the New England Journal of Medicine (NEJM), to summarize the progress of tumor immunotherapy in the past three years and clarify the main lines and trends of frontier progress.

    Play the first part today.

    The speaker introduced that Dr.
    Longo is currently the Deputy Editor of NEJM, responsible for reviews and manuscripts in the field of oncology.

    Professor of Harvard Medical School and concurrently a senior physician at Brigham and Women's Hospital.

    Member of the American Association for the Advancement of Science (AAAS).

    He is also the editor of Harrison's Principles of Internal Medicine.

    He has published more than 980 papers and monograph chapters, and is the author of the top 1% global citation rate in the field of life sciences.

    Dr.
    Longo's scientific research interests focus on the mechanisms of tumor suppression of T cells and other fields.
    He has developed multiple therapies that have improved the survival of patients with tumors such as lymphoma.

    What elements are required for excellent clinical research in the classroom as the editor-in-chief of NEJM? Can negative results be published in high-impact journals? What types of clinical research does the New England Journal of Medicine favor? What are the characteristics of clinical research in various specialties, and what are the cutting-edge developments? We will successively launch clinical research and paper publishing courses led by the editors of the New England Journal of Medicine (NEJM).

    Related reading NEJM Editor-in-Chief Classroom: Excellent Clinical Research from the Perspective of NEJM (Part 1) NEJM Editor-in-Chief Classroom: Excellent Clinical Research from the Perspective of NEJM (Part 2) Copyright information Translation, writing or commissioning of the "NEJM Frontiers in Medicine" jointly created by the Journal of Medicine (NEJM).

    The Chinese translation of the full text and the included diagrams are exclusively authorized by the NEJM Group.

    If you need to reprint, please leave a message or contact nejmqianyan@nejmqianyan.
    cn.

    Unauthorized translation is an infringement, and the copyright owner reserves the right to pursue legal liabilities.

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.